IGR Global Sleep Apnea Devices Market | Page 2

The latest report on Sleep Apnea Devices Market by Infinium Global Research gives complete coverage of the Sleep Apnea Devices Market by product (treatment devices; positive airway pressure machines, masks and diagnostic devices; polysomnography devices, respiratory polygraphs, actigraphy systems), end - user(home care, hospitals) in terms of key trends, market size, forecast and CAGR growth over the period of 2016 to 2022. In addition, the study covers deep dive into key product and applications trends in the regional markets of Sleep Apnea Devices such as North America, Europe, Asia-Pacific and Latin America over the short run and long run. Get Sample Copy of this Report:- https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/293 Some of the key factors attributing for an attractive growth of this market include rising awareness among the population about sleep disorders, increasing prevalence of respiratory disorders, growing usage of oral appliances for the treatment, rise in base of aging population, large number of patient population in the emerging countries with unmet medical needs and changing lifestyle habits. The market for global sleep apnea devices was valued at around USD 5.0 billion in 2015 and is expected to reach USD 8.9 billion by 2022, growing at a CAGR of around 8.7% during the forecast period of 2016 to 2022. However, there are certain restraining factors which could hamper the growth of the market, which includes availability of alternative treatment options for the sleep apnea and lack of patient acquiescence. Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period due to the presence of large base of geriatric population, favorable reimbursement policies and high adoption of advanced technologies in this region. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to growing awareness among the population, and presence of huge patient pool. Infinium Global Research